Biotech Pond Technologies Holdings Inc. Announces Filing of 2025 First Quarter Unaudited Condensed Interim Financial Statements and MD&A July 1, 2025
Biotech Hansa Biopharma presents positive outcomes of five-year follow-up study of imlifidase in kidney transplantation at ESOT Congress 2025 in London June 30, 2025
Biotech ESOT Congress 2025: Scientists create functional human islets in 3D printing breakthrough for type 1 diabetes treatment June 29, 2025
Biotech Challenge accepted: New funding for ambitious projects within biomanufacturing, cardiometabolic diseases, and artificial intelligence June 27, 2025
Biotech Edgewise Therapeutics Reports Positive Results on Sevasemten Program for Becker and Duchenne Muscular Dystrophies June 26, 2025
Biotech BioCity’s ETA-Selective Antagonist SC0062 Granted Breakthrough Therapy Designation in China for Diabetic Kidney Disease with Albuminuria June 26, 2025
Biotech Klotho Neurosciences, Inc. and the Okinawa Research Center for Longevity Science, Leading Experts on the Okinawa “Blue Zone”, Announce a Plan to Study Tissue Levels of the Human Klotho Gene and Protein in the World’s Longest-Lived Population June 25, 2025